Sierhill is a genomic analysis organization advancing precision research through cutting-edge sequencing, bioinformatics, and data-driven discovery.
We bridge the gap between raw genomic data and actionable biological insight.
To accelerate genomic research by providing rigorous, reproducible, and accessible analysis to researchers and institutions worldwide.
Our team combines deep domain knowledge in molecular biology, computational genomics, and statistical genetics to deliver meaningful results.
From rare disease research to population-scale studies, our analyses inform decisions that shape the future of biological and medical science.
End-to-end genomic analysis capabilities designed for modern research.
Comprehensive variant calling, annotation, and interpretation across entire genomes with industry-leading accuracy.
RNA-seq analysis, differential gene expression, pathway enrichment, and single-cell transcriptomics pipelines.
Large-scale GWAS, ancestry inference, and population structure analysis for biobank and cohort studies.
Custom pipeline development, workflow automation, and cloud-native infrastructure for scalable genomic computation.
Methylation profiling, chromatin accessibility analysis, and histone modification mapping for gene regulation studies.
Strategic guidance on study design, grant applications, data management plans, and analytical strategy for genomic projects.
A disciplined, reproducible workflow from sample to insight.
We work closely with your team to understand research questions, sample characteristics, and desired outcomes.
Raw sequencing data undergoes quality control, alignment, and variant calling using validated, version-controlled pipelines.
Statistical and computational methods are applied to extract biologically meaningful signals from processed data.
Clear, publication-ready reports with interactive visualizations, methods documentation, and full reproducibility artifacts.
Ready to start your genomic analysis project? We'd love to hear from you.
We partner with academic institutions, biotech companies, and research consortia. Reach out to discuss how we can support your work.